T Cell Therapy
Specialized Cell Therapy Systems products to isolate, activate, expand, and genetically modify T cells, dendritic cells, or other immune cell types.
The Gibco™ CTS™ Rotea™ Counterflow Centrifugation System is an award-winning, highly versatile tool designed for cell separation, concentration, washing, and buffer exchange. Utilizing innovative Counterflow Centrifugation (CFC) technology, the system suspends cells in a fluidized bed by exerting a constant flow force opposing centrifugal forces. This unique mechanism provides capabilities beyond traditional centrifuges, delivering high cell recovery and viability in a closed, automated environment from process development through commercialization.
The CTS Rotea System is engineered to support a broad range of functionalities across the cell therapy workflow:
Advanced Cell Processing: Optimized for T cell, NK cell, and MSC wash and concentration.
Specialized Harvesting: Enables MSC harvesting from Cell Factory Systems and iPSC aggregate processing.
Viral Vector Manufacturing: Suitable for Lentiviral vector clarification and residual wash out applications.
Precision Separations: Facilitates PBMC/monocyte separation, RBC depletion, and elutriation.
Quality & Research: Ideal for QC sample prep, isolation, and small- to mid-scale cell processing.
Superior Recovery and Viability: Gentle processing enables >95% cell recovery while maintaining high cell viability.
Low-Volume Output: Proprietary DirectDraw extraction technology can deliver as little as 5 mL of concentrate, providing highly concentrated cell populations.
Live Visualization: Integrated Gibco™ CellCam™ video technology allows users to visualize cells live in the fluidized bed for precise parameter optimization.
Customer-Controlled Development: User-friendly software enables the creation, modification, and assessment of custom protocols to suit unique applications.
Flexible Input Range: Supports a wide recommended input volume range from 50 mL up to 20 L.
Rapid Processing: Capable of washing and concentrating 1 L of cells in approximately 18 minutes or isolating PBMCs from a full leukopak bag in about 85 minutes.
Modular Integration: Designed for easy integration into existing workflows, allowing for a seamless transition from research to GMP manufacturing.
Sterile, Closed System: Single-use kits enable sterile processing in Class C cleanroom facilities, reducing the requirement for high-grade lab space by up to 90%.
Regulatory Support: Manufactured in an ISO 13485-certified facility with software options designed to help enable 21 CFR Part 11 compliance.
Digital Connectivity: Features an OPC-UA interface for connection to MES/LIMS platforms and available CTS™ Cellmation™ Software for integration with DeltaV™ systems.
Whether you’re developing an induced pluripotent stem cell therapy, specialized immunotherapy, or a gene therapy, our Gibco CTS portfolio offers cell-type and viral vector specific applications that can be leveraged to advance your research to the clinic and beyond.
Specialized Cell Therapy Systems products to isolate, activate, expand, and genetically modify T cells, dendritic cells, or other immune cell types.
Explore cell therapy systems products for expansion, processing, and gene editing of human natural killer (hNK) cells for cell therapy development.
Learn more about our solutions across the pluripotent stem cell workflow, from reprogramming to culture.
Specialized cell therapy products for stem cell– and tissue-derived neural cell cultures.
We offer complete, optimized systems for scalable, cost-effective adeno-associated virus (AAV) and lentivirus (LV) vector production.
| Manufacturer | Thermo Fisher Scientific |
|---|